EGFR-IN-215 (Compound 019) is an EGFR inhibitor with IC 50 values for the L858R BaF3 and L858R/C797S mutant forms of both ≤ 0.25 μM. EGFR-IN-215 can be used in cancer research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > EGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.